Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Medeliver Intracranial Drug Coated Balloon Catheter for Symptomatic Intracranial Atherosclerotic Stenosis(Prospective, Multicenter, Randomized Controlled, Superiority Trial)

NCT07542938 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.

NCT NCT07542938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07542938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Medeliver Intracranial Drug Coated Balloon Catheter for Symptomatic Intracranial Atherosclerotic Stenosis(Prospective, Multicenter, Randomized Controlled, Superiority Trial)
Lead sponsor
Xuanwu Hospital, Beijing
Phase
Not applicable
Overall status
Recruiting
Start date
April 15, 2026
Completion date
November 30, 2027
Enrollment
264 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic intracranial atherosclerotic stenosis